Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Ludwig Institute for Cancer Research receives NHMRC's largest 2009 grant

Abstract:
$20 million to tackle most common cancer in Australia

Ludwig Institute for Cancer Research receives NHMRC's largest 2009 grant

Australia | Posted on February 5th, 2008

Australia's National Health & Medical Research Council (NHMRC) has awarded its largest grant for 2009 to the Ludwig Institute for Cancer Research (LICR) in Melbourne.

This grant will allow the LICR to bring together 18 key investigators from five Melbourne institutions to develop new ways of detecting and treating cancers of the colon and rectum, the most common form of cancer in Australia. More than 12,000 people are diagnosed each year with colon cancer and more than one third of those people - 4,000 Australians - will die as a result of this disease.

The Melbourne group, which combines laboratory and clinical investigators, will tackle five key projects relating to the discovery and analysis of the genetic causes of colon cancer, the development of biomarkers for the early detection of colon cancer and the continuing development of therapies targeted specifically to colon cancer cells, including antibody- and nanoparticle-mediated delivery of therapeutics.

According to LICR Melbourne Branch Director, Professor Tony Burgess, the principal investigator of the NHMRC grant, this large award to a collaborative group is consistent with the changing paradigm of cancer research. "Over the past decade or so, we've moved away from small groups working on individual aspects of a research problem, to larger collaborative groups in which researchers from multiple disciplines can combine their knowledge and expertise. To progress our efforts to combat colon cancer, we needed to bring together top-quality scientific and clinical minds. This grant creates the collaborative opportunity to improve outcomes for colon cancer patients".

####

About Ludwig Institute for Cancer Research
The LICR Melbourne Branch, located at the Royal Melbourne Hospital, and the LICR Melbourne Centre, located at the Austin Hospital, are part of the world’s largest cancer research institute. LICR currently has ten branches in seven countries with an 11th site planned in Singapore. The non-profit Institute’s infrastructure allows it to patent research discoveries, and sponsor and conduct its own clinical trials in Europe, North America and Australasia, meaning that any research findings from the group can be translated rapidly into early-phase clinical trials. Professor Burgess is leading the ‘LICR Colon Cancer Initiative,’ the Institute’s international effort in CRC research.

For more information, please click here

Contacts:
Caroline Cody

61-039-341-3155

Copyright © Ludwig Institute for Cancer Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

Nanomedicine

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Brookhaven's Oleg Gang Named a Battelle 'Inventor of the Year': Recognized for work using DNA to guide and regulate the self-assembly of nanoparticles into clusters and arrays with controllable properties April 25th, 2016

Zip software can detect the quantum-classical boundary: Compression of experimental data reveals the presence of quantum correlations April 21st, 2016

Making electronics out of coal: Instead of burning up this complex hydrocarbon, let's make devices from it April 20th, 2016

Nano-magnets produce 3-dimensional images: Wide-view 3-dimensional holographic display composed of nano-magnetic pixels April 20th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic